Breaking Business News | Breaking business news AM | Breaking Business News PM | Uncategorized

Aspen revenue up, but warns of ‘inevitable’ Covid-19 threat

6 Mar 2020

JSE-listed drug maker Aspen Pharmacare reported a 3percent increase in revenue to R18.4billion for the six months to end December.

Read the full article here.
This content was originally published by IoL Business Report. Original publishers retain all rights. It appears here for a limited time before automated archiving. By IoL Business Report

Covid-19 – Johns Hopkins University

Download brochure

Introduction brochure

What we do, case studies and profiles of some of our amazing team.